Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2.12M Sell
9,605
-15,822
-62% -$3.87M 0.15% 234
2025
Q4
$6.45M Buy
25,427
+9,834
+63% +$2.47M 0.51% 43
2025
Q3
$3.86M Sell
15,593
-4,280
-22% -$1.02M 0.29% 98
2025
Q2
$4.77M Buy
19,873
+7,084
+55% +$1.65M 0.42% 56
2025
Q1
$2.9M Buy
12,789
+8,263
+183% +$1.82M 0.36% 82
2024
Q4
$930K Buy
4,526
+810
+22% +$178K 0.12% 250
2024
Q3
$901K Buy
3,716
+1,020
+38% +$239K 0.09% 265
2024
Q2
$592K Buy
+2,696
New +$586K 0.06% 318
2024
Q1
Sell
-3,957
Closed -$870K 667
2023
Q4
$870K Buy
3,957
+2,836
+253% +$600K 0.15% 202
2023
Q3
$246K Buy
+1,121
New +$254K 0.06% 344

Other funds holding STE

Atom Investors's STE Position: Q1 2026 in Review

Atom Investors reduced its Steris (STE) stake by 62% in Q1 2026, selling an estimated $3.87M and leaving 9,605 shares worth $2.12M. The position accounts for 0.15% of the portfolio, ranked #234.

Atom Investors first reported a position in STE in Q3 2023 and has held it in 10 quarters since. The position peaked at $6.45M in Q4 2025. 838 funds tracked by Wall St. Rank hold STE as of Q1 2026.

  • Atom Investors held 9,605 shares of Steris worth $2.12M as of Q1 2026.
  • Atom Investors sold 15,822 Steris shares in Q1 2026, an estimated $3.87M.
  • Steris made up 0.15% of Atom Investors's portfolio in Q1 2026, its #234 holding.
  • Atom Investors first reported a position in Steris in Q3 2023 and has held it in 10 quarters since.
  • Atom Investors's Steris position peaked at $6.45M in Q4 2025.
  • 838 funds tracked by Wall St. Rank held Steris as of Q1 2026.

Based on Atom Investors's 13F filing for Q1 2026, filed 15 May 2026.